The interaction of IL-2 and IL-4 with the effects of deoxyspergualin.
Kerr
P G
PG
Department of Nephrology, Prince Henry's Hospital, Melbourne, Australia.
Atkins
R C
RC
D002460:Cell Line; D002478:Cells, Cultured; D003602:Cytotoxicity, Immunologic / Q000187:drug effects*; D004261:DNA Replication / Q000187:drug effects; D006146:Guanidines / Q000494:pharmacology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D007376:Interleukin-2 / Q000494:pharmacology*; D015847:Interleukin-4 / Q000494:pharmacology*; D007700:Kinetics; D008213:Lymphocyte Activation / Q000187:drug effects*; D008214:Lymphocytes / Q000187:drug effects / Q000276:immunology*; D011994:Recombinant Proteins / Q000494:pharmacology; D013602:T-Lymphocytes, Cytotoxic / Q000187:drug effects / Q000276:immunology
D006146:Guanidines; D007166:Immunosuppressive Agents; D007376:Interleukin-2; D011994:Recombinant Proteins; D015847:Interleukin-4; C037258:gusperimus